You are here

eye health

Built from biotech parts, Beacon launches with $120M to develop eye gene therapies

BioPharma Dive

Mon, 06/12/23 - 11:26 pm

Beacon Therapeutics

Astellas to acquire eye drug developer Iveric Bio for $5.9B

BioPharma Dive

Mon, 05/1/23 - 11:13 am

JPM23: Is Novartis weighing respiratory, eye drug sell-offs after Sandoz? Not necessarily, CEO says

Fierce Pharma

Mon, 01/9/23 - 10:43 pm

Novartis sells U.S. rights to five drugs to Harrow for up to $175M

Medical Marketing and Media

Wed, 12/14/22 - 07:43 pm

Viatris to buy two eye drug developers in deals worth up to $750M

BioPharma Dive

Mon, 11/7/22 - 05:29 pm

Oyster Point Pharma

Famy Life Sciences

EyeBio raises $65m in Series A round: ‘Our goal is to build a broad and diverse pipeline of therapies for the eye’

Biopharma Reporter

Wed, 03/2/22 - 09:56 am

A new eye-focused biotech is out of stealth, with plans to barrel toward PhII studies

Endpoints

Wed, 12/15/21 - 11:45 pm

Aramis Biosciences

Visus, with one drug chasing AbbVie, inks deals to grow pipeline

Fierce Biotech

Thu, 08/19/21 - 10:45 am

Visus Therapeutics

Unity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug

Xconomy

Tue, 09/15/20 - 11:03 am

Unity Biotechnology

Horizon looks to the future with massive San Francisco manufacturing, R&D plant

Fierce Pharma

Wed, 12/4/19 - 10:29 am

Horizon Therapeutics

drug manufacturing

Artificial Intelligence tech tool can now detect nearly 50 eye diseases faster than human doctors

Forbes

Fri, 11/22/19 - 10:13 am

artificial intelligence

Google DeepMind

EyeGate shares jump on data for eye treatment data

Marketwatch

Fri, 11/22/19 - 09:58 am

corneal wound repair

Biogen turns to eye, immune diseases to balance neuro gamble

Biopharma Dive

Wed, 07/24/19 - 12:26 pm

Clover Therapeutics Launches With Eye on Age-Related Ocular Diseases

BioSpace

Thu, 07/11/19 - 05:28 pm

Clover Therapeutics

Alcon Beats Expectations Since its Split from Novartis

Medical Devices and Diagnostics Industry

Fri, 05/17/19 - 07:13 pm

ReNeuron climbs on up dated vision loss cell therapy data

Fierce Biotech

Fri, 04/26/19 - 10:13 am

Retinitis pigmentosa

Glaukos touts 5-year study of glaucoma stents

Mass Device

Mon, 04/15/19 - 11:09 pm

Lukewarm data for Second Sight

EP Vantage

Sat, 04/13/19 - 12:21 pm

retinal prosthesis

Novartis completes spin-out of Alcon eye unit

Pharmaforum

Tue, 04/9/19 - 08:21 am

Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases

Xconomy

Mon, 04/8/19 - 09:56 am

Pages